NCT06129019

Brief Summary

During Reiki application, individuals may report feeling a slight warm sensation under and near the therapist's hand. The only rule in Reiki practice is that the individual must give permission to the practitioner to facilitate the flow of energy. The person receiving Reiki during the application does not have to believe in Reiki. Because Reiki is universal life energy and is available to everyone. Reiki is generally safe and no serious side effects have been reported. Reiki practice in the last 10 years; It is increasing among physicians, nurses and other healthcare professionals. This study was planned to investigate the effect of reiki application on depression, anxiety and physical activity in individuals diagnosed with Relapsing-Remitting Multiple Sclerosis. Geri bildirim gönder Yan paneller

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 8, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 13, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

January 7, 2025

Status Verified

January 1, 2025

Enrollment Period

10 months

First QC Date

November 8, 2023

Last Update Submit

January 6, 2025

Conditions

Keywords

reikianxietyphysical activity

Outcome Measures

Primary Outcomes (3)

  • Beck Depression Scale

    The scale was administered to investigate each participant's feelings and attitudes regarding the general depressive state. Each patient was asked to read several groups of statements and then mark the one statement in each group that best described how he or she felt "during the past week." BDI, which evaluates four statements describing increasing intensities of depressive symptoms between 0 and 3 points, includes 21 items. Depressive symptoms were classified as follows: minimal-to-moderate depressive symptoms (range 14 to 19), moderate-to-severe depressive symptoms (range 20 to 29), severe depressive symptoms (range 30 to 63).

    4 week

  • Beck Anxiety Scale

    BAI is a self-rating scale developed by Beck et al. (1988) and used to determine the frequency of anxiety symptoms experienced by individuals. It is a Likert-type scale consisting of 21 items and scored between 0-3. Its validity and reliability in Turkey were determined by Ulusoy et al.

    4 week

  • International Physical Activity Survey

    There are some scales that can be used in primary care to evaluate physical mobility. One of these is the "International Physical Activity Questionnaire", which was developed by the International Consensus Group consisting of researchers from various countries with the support of the World Health Organization and the Center for Disease Control, to be used to measure physical activity and inactivity in 1997 and 1998; (IPAQ)" is a standard tool. Reliability and/or validity studies were conducted in 14 centers from 12 countries in 2000 for at least two of the four long (IPAQ-long) and four short (IPAQ-SF) forms of the IPAQ. This scale was adapted into Turkish as long form (UF) and short form (SF) under the name "International Physical Activity Questionnaire (UFAA)" and its validity and reliability study was conducted by Sağlam et al. in 2010

    4 week

Study Arms (2)

Experimental:

EXPERIMENTAL

Reiki application will be done

Behavioral: Reiki

Control

NO INTERVENTION

Reiki application will not be done

Interventions

ReikiBEHAVIORAL

Reiki application will be done

Experimental:

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being over 18 years of age
  • Having the ability to use technological devices
  • Not using Reiki and similar integrative treatment methods
  • No verbal communication disability (hearing and speaking)
  • Not having a diagnosed psychiatric disorder
  • Patients who have been receiving Relapsing-Remitting MS treatment for more than three months

You may not qualify if:

  • Patients using any complementary alternative treatment methods
  • Patients who cannot communicate by phone to participate in remote reiki application
  • Patients with autoimmune diseases other than multiple sclerosis
  • Patients with communication disabilities
  • Patients with another known neurological system disease (dementia, Alzheimer's, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Firat University

Elâzığ, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Multiple Sclerosis, Relapsing-RemittingAnxiety DisordersMotor Activity

Interventions

Therapeutic Touch

Condition Hierarchy (Ancestors)

Multiple SclerosisDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesMental DisordersBehavior

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual Therapies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 8, 2023

First Posted

November 13, 2023

Study Start

June 1, 2023

Primary Completion

April 1, 2024

Study Completion

June 1, 2024

Last Updated

January 7, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations